Gebhardt Deborah McKeithan - 31 Dec 2025 Form 4 Insider Report for SENSIENT TECHNOLOGIES CORP (SXT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Jan 2026, 15:43:54 UTC
Prior SEC filing
01 Oct 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John J. Manning, Attorney-in-Fact for Ms. McKeithan-Gebhardt

Key filing fact

Gebhardt Deborah McKeithan filed Form 4 for SENSIENT TECHNOLOGIES CORP (SXT) on 02 Jan 2026.

Key facts

  • This page summarizes Gebhardt Deborah McKeithan's Form 4 filing for SENSIENT TECHNOLOGIES CORP (SXT).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 02 Jan 2026, 15:43.

Change

  • Previous filing in this sequence was filed on 01 Oct 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001616603 Primary reporting owner

McKeithan Gebhardt Deborah

Relationship
Director
Address
777 EAST WISCONSIN AVENUE, MILWAUKEE
Signature
/s/ John J. Manning, Attorney-in-Fact for Ms. McKeithan-Gebhardt
Signature date
02 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SXT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
16,394
Date
31 Dec 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SXT transaction Derivative

Deferred Stock

Award

Transaction value
$0
Shares
+103
Change %
+1.8%
Price
$0.000000
Shares after
5,702
Date
31 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
103
Exercise price
Footnotes
F2, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.

Footnote F2

Deferred stock converts to common stock on a one-for-one basis.

Footnote F3

Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.

Footnote F4

Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .